Colgate-Palmolive Co. stock rises Thursday, outperforms market

Shares of Colgate-Palmolive Co. CL, +0.38% inched 0.38% higher to $78.25 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX, +0.31% rising 0.32% to 3,385.51 and the Dow Jones Industrial Average DJIA, +0.16% rising 0.17% to 27,739.73. This was the stock’s fifth consecutive day of gains. Colgate-Palmolive Co. hit a new 52-week high, surpassing its previous peak of $78.19, which the company achieved on August 19th.

No IPO? No problem: Alzheon bags $47M NIH grant to bankroll Alzheimer’s trial

Alzheon has been trying to go public for years, calling off its IPO in April 2018 and aborting its second attempt in January last year. Now, public markets be damned, the company is moving forward with a phase 3 study of its lead Alzheimer’s disease program thanks to a $47 million grant from the National Institutes of Health’s National Institute on Aging (NIA).

error: Content is protected !!